tag launch-environment 
Pharmaceutical Technology
JULY 14, 2022
Such movements have enabled pharmaceutical companies to increase their focus on rare diseases, and the number of orphan drug launches is steadily increasing. The choice of where to launch an orphan drug is an important and difficult decision. The choice of where to launch an orphan drug is an important and difficult decision.
pharmaphorum
AUGUST 18, 2022
The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rep-Lite
MARCH 21, 2024
Aligning incentives with strategic goals or launches encourages them to prioritize sales efforts effectively. This approach promotes teamwork and creates a positive work environment. There are rungs and each comes with both a price tag and an incentive. Here are a few examples.
pharmaphorum
AUGUST 26, 2022
million for the one-shot therapy – in other words, after any discounts that it may offer or outcomes-based agreements – aiming to launch first in Germany followed by France. BioMarin has said Roctavian will be available at a ‘net’ price of around €1.5 million spread over five years. million spread over five years.
Healthcare Success
NOVEMBER 17, 2023
Don’t forget to announce your new brand properly Crafting a comprehensive healthcare marketing and communications strategy around a new brand launch is essential for effectively conveying your rebranded messaging to your audience. Creating a warm and welcoming environment instills a sense of trust and loyalty among your patients.
Evolve Your Success
DECEMBER 27, 2022
They also wanted to launch a brand for the OR. They launched a couple of years ago. You could say the rest is history because our first podcast launched in January of 2021, and we are still going strong. You can’t put a price tag on that relationship, especially when you’re like, “I need help. What does First Case do ?
Pharmaceutical Technology
MARCH 17, 2023
On 16 March, Watt spoke at GlobalData webinar titled “Pharma [POLI]: Market Access Risk Outlook”, providing a current outlook on the pharmaceutical pricing and reimbursement environments around the world, including key reforms, risks and opportunities. GlobalData is the parent company of Pharmaceutical Technology.
Expert insights. Personalized for you.
59 
Let's personalize your content